https://www.globenewswire.com/news-release/2025/04/25/3068387/0/en/CHMP-recommends-EU-approval-for-Duvyzat-to-treat-Duchenne-muscular-dystrophy.html
CHMP recommends EU approval for Duvyzat to treat Duchenne
Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment...
chmprecommendseuapprovalduvyzat
https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-duvyzat
Drug Trials Snapshots: DUVYZAT | FDA
DUVYZAT is a histone deacetylase inhibitor that is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
drug trials snapshotsduvyzatfda
https://www.goodrx.com/duvyzat/what-is
Duvyzat (givinostat): Uses, Side Effects, Dosage & Reviews
Learn about Duvyzat (givinostat) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
side effectsduvyzatgivinostatusesdosage